Shapiro David has filed 5 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 60000 shares of Design Therapeutics, Inc. ($DSGN) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Design Therapeutics, Inc. | $DSGN | Shapiro David | Not found | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 56,963,757 | 9999.99% | 0.11% |
| March 31, 2026 | Design Therapeutics, Inc. | $DSGN | Shapiro David | Not found | A | Stock option (right to buy) | 7500 | $0.00 | 7,500.0000 | 56,963,757 | 9999.99% | 0.01% |
| June 18, 2025 | Damora Therapeutics, Inc. | $DMRA | Shapiro David | Not found | A | Stock Option (right to buy) | 720 | $0.00 | 720.0000 | 1,322,359 | 9999.99% | 0.05% |
| June 20, 2024 | Damora Therapeutics, Inc. | $DMRA | Shapiro David | Not found | A | Stock Option (right to buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Damora Therapeutics, Inc. | $DMRA | Shapiro David | Director | A | Stock Option (right to buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |